Mission Bio: Yan Zhang, Charlie Silver
Single-cell analysis firm Mission Bio has appointed Yan Zhang as CEO.
Zhang joins Mission Bio after 10 years at Thermo Fisher Scientific, where she led that firm's commercial organization in China for genetic sciences and clinical next-generation sequencing and was general manager for its reproductive health and microarray businesses.
Prior to Thermo, Zhang held product management and commercialization roles at Affymetrix, NuGen Technologies, and Molecular Devices. She holds a PhD in biochemistry from the Medical College of Wisconsin.
Former CEO Charlie Silver, a Mission Bio cofounder, will move into an advisory role.
Akoya Biosciences: Frederick Pla
Akoya Biosciences has appointed Frederic Pla as its chief operating officer. Pla most recently served as chief operating officer at the Parker Institute for Cancer Immunotherapy. Prior to this, Pla served as COO at Genomic Health before its acquisition by Exact Sciences in 2019. He has also served in leadership positions at Life Technologies, GE Healthcare, and NASA.
Micronoma: Jennifer Wargo
Micronoma, a company using signals from the tumor-related microbiome for liquid biopsy-based cancer diagnosis, has appointed Jennifer Wargo to its scientific advisory board. Wargo is a professor of surgical oncology and genomic medicine at the University of Texas MD Anderson Cancer Center.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.